P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network

C.M.  Sloan; L.J.  Sherrard; G.G.  Einarsson; L.J.  Dupont; S. van Koningsbruggen-Rietschel; N.J.  Simmonds; D.G.  Downey

doi:10.1016/S1569-1993(23)00625-2

P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network

C.M. Sloan, L.J. Sherrard, G.G. Einarsson, L.J. Dupont, S. van Koningsbruggen-Rietschel, N.J. Simmonds, D.G. Downey

Research output: Contribution to journal › Meeting abstract › peer-review

Abstract

Original language	English
Article number	S143
Journal	Journal of Cystic Fibrosis
Volume	22
Issue number	Supplement 2
DOIs	https://doi.org/10.1016/S1569-1993(23)00625-2
Publication status	Published - 09 Jun 2023
Event	46th European Cystic Fibrosis Conference - Vienna, Austria Duration: 07 Jun 2023 → 10 Jun 2023

Access to Document

10.1016/S1569-1993(23)00625-2Licence: Unspecified

Cite this

Sloan, C. M., Sherrard, L. J., Einarsson, G. G., Dupont, L. J., van Koningsbruggen-Rietschel, S., Simmonds, N. J., & Downey, D. G. (2023). P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network. Journal of Cystic Fibrosis, 22 (Supplement 2), [S143]. https://doi.org/10.1016/S1569-1993(23)00625-2

@article{cdbabba703c645ad9e3a2ccfa26b9cdd,

title = "P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network",

author = "C.M. Sloan and L.J. Sherrard and G.G. Einarsson and L.J. Dupont and {van Koningsbruggen-Rietschel}, S. and N.J. Simmonds and D.G. Downey",

year = "2023",

month = jun,

day = "9",

doi = "10.1016/S1569-1993(23)00625-2",

language = "English",

volume = "22 ",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier Inc.",

number = "Supplement 2",

note = "46th European Cystic Fibrosis Conference ; Conference date: 07-06-2023 Through 10-06-2023",

}

Sloan, CM , Sherrard, LJ , Einarsson, GG, Dupont, LJ, van Koningsbruggen-Rietschel, S, Simmonds, NJ & Downey, DG 2023, 'P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network', Journal of Cystic Fibrosis, vol. 22 , no. Supplement 2, S143. https://doi.org/10.1016/S1569-1993(23)00625-2

P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network. / Sloan, C.M. ; Sherrard, L.J. ; Einarsson, G.G. et al.

In: Journal of Cystic Fibrosis, Vol. 22 , No. Supplement 2, S143, 09.06.2023.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network

AU - Sloan, C.M.

AU - Sherrard, L.J.

AU - Einarsson, G.G.

AU - Dupont, L.J.

AU - van Koningsbruggen-Rietschel, S.

AU - Simmonds, N.J.

AU - Downey, D.G.

PY - 2023/6/9

Y1 - 2023/6/9

U2 - 10.1016/S1569-1993(23)00625-2

DO - 10.1016/S1569-1993(23)00625-2

M3 - Meeting abstract

VL - 22

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

SN - 1569-1993

IS - Supplement 2

M1 - S143

T2 - 46th European Cystic Fibrosis Conference

Y2 - 7 June 2023 through 10 June 2023

ER -

Sloan CM , Sherrard LJ , Einarsson GG, Dupont LJ, van Koningsbruggen-Rietschel S, Simmonds NJ et al. P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network. Journal of Cystic Fibrosis. 2023 Jun 9;22 (Supplement 2):S143. doi: 10.1016/S1569-1993(23)00625-2

P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network

Abstract

Access to Document

Fingerprint

Cite this